Early research (Phase 1)Active Not RecruitingNCT05789069
What this trial is testing
HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
Who this might be right for
Renal Cell CarcinomaMelanomaNon Small Cell Lung Cancer+2 more
HiFiBiO Therapeutics 83